COSHH Health Surveillance: When Do Workers Need It?

COSHH health surveillance is a planned way to detect relevant changes in workers' health where the risk assessment shows it is necessary. It is separate from air or surface monitoring, which measures exposure or contamination. A programme has value only when findings are interpreted and acted on to protect workers.

When should an employer consider health surveillance?

The Health and Safety Executive (HSE) says surveillance is necessary when a disease is associated with the substance in use, it is possible to detect the disease or adverse change and reduce further harm, and workplace conditions make the disease likely. See HSE's COSHH health surveillance guidance. Examples may involve asthma or dermatitis risks, but the decision must reflect the specific task and exposure conditions rather than a product category alone.

Start with the COSHH assessment. What substances are present, how are people exposed, for how long, and how reliable are the controls? Have there been symptoms, incidents or changes in work? HSE's assessment guidance asks for exposure routes, frequency, duration, people affected and control measures. Those details support a competent occupational health decision on the appropriate surveillance method and frequency.

Do not treat surveillance as a universal add-on for every SDS. Conversely, do not rule it out because a product has a modest hazard label if the work creates a significant exposure. Workers and tasks, not just bottles, are the unit of assessment.

How is surveillance different from exposure monitoring?

Exposure monitoring measures a substance in air, on a surface or in the body to help judge control performance. Health surveillance collects information about a worker's health to detect adverse changes or disease. HSE states that surveillance objectives include early detection, collecting data on health hazards and evaluating controls. Its exposure monitoring guide explicitly distinguishes monitoring from the state of a worker's health.

The two may inform each other but neither is a substitute for the other. A low air result on one day does not necessarily rule out skin contact or a past exposure pattern. A worker reporting symptoms should prompt a review of the work, even when controls appear sound on paper. Interpretation may require occupational health expertise, and a manager should not infer a diagnosis from a questionnaire score.

Surveillance can include planned checks relevant to the hazard, such as skin assessment or lung-function assessment in appropriate circumstances. HSE says some surveillance may need a doctor or nurse with occupational health competence. The method should be selected by appropriate professionals for the actual risk; a generic online form is not a clinical programme.

What should happen after a finding?

HSE says tests, questionnaires or examinations alone are insufficient. Results must be interpreted and action taken to eliminate or further control exposure where needed. Depending on the case, this may mean examining ventilation, working methods, protective equipment, maintenance, training or task assignment. The employer should get competent advice on individual work restrictions or redeployment where necessary.

Review whether other workers doing the same task may be exposed in the same way. A cluster of skin complaints may indicate a control problem even if each case was initially managed individually. Preserve confidentiality while using appropriate aggregated information to improve the workplace. A worker should be told what the programme is for, how results will be handled and how concerns can be raised.

Keep the response tied to the task assessment. If the substance, method or control changes, revisit the surveillance decision as well. HSE's control principles stress that exposure controls need continuing review; surveillance evidence can be one signal that a control is failing.

How should records and privacy be handled?

Separate the employer's health surveillance record from confidential clinical information. HSE's COSHH FAQ explains that medical records are created and held by a competent health professional, while employers keep appropriate health surveillance records and receive general information needed to manage risk. Access should be limited according to role and purpose.

Record the link between the relevant task, substances, surveillance decision and actions without copying private medical detail into a general chemical register. The assessment workflow can help keep hazard and task information organised; personal health data needs a separate, controlled route. Train managers to escalate symptoms and control failures, not to diagnose them.

The programme should end in a workplace decision: controls remain effective, further investigation is needed or the method must change. A calendar of tests without that feedback does not protect people.

What would a proportionate decision look like?

Imagine a workshop introducing a product with a recognised skin-sensitisation concern. The assessment first describes the contact route, frequency and controls, including transfer equipment, cleaning and gloves. An occupational health adviser then considers whether the conditions meet the criteria for surveillance and what form would be useful. The employer does not simply buy a generic annual questionnaire because the product has a hazard statement; nor does it ignore the possibility because workers have not yet reported symptoms.

If a programme is advised, explain its purpose to the affected workers. They should know what information they will provide, who will see individual findings and how a concern is raised between planned checks. The manager should receive the advice needed to improve the workplace without collecting unnecessary clinical detail. Record the decision and the reason so it can be revisited if the task changes.

How can findings improve prevention?

Suppose several workers report irritation after a new cleaning step. Review the product, concentration, contact time, glove use, washing facilities and contaminated surfaces. Ask whether the method can avoid contact at source. The correct response may be a closed dispenser or different cleaning method, not simply more frequent checks of skin condition.

Use a written action trail: the concern, the task reviewed, the control changed, the person responsible and how effectiveness will be checked. Monitor whether workers can use the new control in practice. If the issue remains, seek further competent advice. A surveillance programme should make the workplace safer over time; it should never normalise avoidable exposure by treating symptoms as routine.

What should a manager do between planned checks?

Workers need a route to report symptoms or concerns as they arise. A manager should note the task and control conditions, seek appropriate occupational health advice and review whether an exposure problem may affect others. Waiting for the next scheduled surveillance appointment can delay a needed control change. At the same time, the manager should avoid diagnosing an individual or discussing personal findings with colleagues.

Check whether a new product, failed extraction, revised rota or change in cleaning practice coincided with the concern. Record the workplace findings and corrective action separately from confidential medical information. If a control is changed, verify it during normal work and ask workers whether the method is practical. A surveillance programme only closes the loop when health signals lead to better prevention.

Keep the decision about surveillance under review. A change in task, product, exposure or control reliability may alter whether it is necessary and what form it should take. Record who made that decision and on what evidence. That makes the programme responsive to the workplace rather than an unexamined annual routine.

Workers should know how to raise concerns between checks.

The help centre can support organising product records separately from clinical information.